Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.46 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | ADH4 | P08319 | 1/20 | 0.43 |
| ▸ | ADH7 | P40394 | 1/20 | 0.43 |
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.41 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3614541 | 1.00 | OPRM1 (0.50) | OPRM1TSHRTHRBSPHK1LMNA | |
| SCHEMBL3139935 | 1.00 | — | — | |
| SCHEMBL276302 | 1.00 | OPRM1 (0.50) | OPRM1TSHRTHRBSPHK1LMNA | |
| SCHEMBL3623090 | 1.00 | OPRM1 (0.50) | OPRM1TSHRTHRBSPHK1LMNA | |
| SCHEMBL3614681 | 1.00 | OPRM1 (0.50) | OPRM1TSHRTHRBSPHK1LMNA | |
| SCHEMBL3625245 | 1.00 | OPRM1 (0.50) | OPRM1TSHRTHRBSPHK1LMNA | |
| SCHEMBL276706 | 1.00 | OPRM1 (0.50) | OPRM1TSHRTHRBSPHK1LMNA | |
| SCHEMBL7062722 | 1.00 | OPRM1 (0.50) | OPRM1TSHRTHRBSPHK1LMNA | |
| SCHEMBL3622070 | 1.00 | OPRM1 (0.50) | OPRM1TSHRTHRBSPHK1LMNA | |
| SCHEMBL3614475 | 1.00 | OPRM1 (0.50) | OPRM1TSHRTHRBSPHK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114891027-A | Infrared-response N-type organic molecule and application thereof | 广州光达创新科技有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-110300772-B | Polyoxazolidinones and process for their preparation | 巴斯夫欧洲公司 | 2022-04-26 | — | — | CN | disclosed |
| US-8669375-B2 | Process for producing ester compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-03-11 | — | — | US | disclosed |
| US-20130066070-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-03-14 | — | — | US | disclosed |
| US-8318964-B2 | Process for producing ester compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| CN-102017264-A | Ionic liquid-containing catalyst ink and the use thereof in the production of electrodes, CCMs, GDEs and MEAs | BASF SE | 2011-04-13 | — | — | CN | disclosed |
| US-20100324314-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
| US-20090203817-A1 | STABILIZED SPANDEX COMPOSITIONS | CYTEC TECHNOLOGY CORP. | 2009-08-13 | — | — | US | disclosed |
| EP-1976505-A1 | COMBRETASTATIN DERIVATIVES AND RELATED THERAPEUTIC METHODS | Abraxis BioScience, Inc. (US) | 2008-10-08 | — | — | EP | disclosed |
| WO-2007120749-A1 | STABILIZED SPANDEX COMPOSITIONS | CYTEC TECHNOLOGY CORP. (US) | 2007-10-25 | — | — | WO | disclosed |
| US-5650430-A | Radicicol derivatives, their preparation and their anti-tumor activity | SANKYO COMPANY, LIMITED (JP) | 1997-07-22 | — | — | US | disclosed |
| US-5597846-A | ESTERS OF RADICICOL | SANKYO COMPANY, LIMITED (JP) | 1997-01-28 | — | — | US | disclosed |
| US-5518870-A | Silver halide color photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1996-05-21 | — | — | US | disclosed |
| EP-0368340-B1 | Method for processing silver halide color photosensitive materials | FUJI PHOTO FILM CO LTD (JP) | 1995-02-01 | — | — | EP | disclosed |
| WO-1991018905-A1 | RADICICOL DERIVATIVES, THEIR PREPARATION AND THEIR ANTI-TUMOR ACTIVITY | SANKYO COMPANY LIMITED (JP) | 1991-12-12 | — | — | WO | disclosed |
| EP-0460950-A1 | Radicicol derivatives, their preparation and their anti-tumour activity | Sankyo Company Limited (JP) | 1991-12-11 | — | — | EP | disclosed |
| US-H809-H | PYRAZOLOAZOLE MAGENTA COUPLER, HYDRAZINE OR HYDRAZIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1990-08-07 | — | — | US | disclosed |
| EP-0368340-A1 | Method for processing silver halide color photosensitive materials | FUJI PHOTO FILM CO., LTD. (JP) | 1990-05-16 | — | — | EP | disclosed |
| EP-0325277-A2 | A method for processing a silver halide color photograhic material | FUJI PHOTO FILM CO., LTD. (JP) | 1989-07-26 | — | — | EP | disclosed |
| EP-0325276-A2 | Method for processing silver halide color photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1989-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130066070-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | ADH1C, ADH5, ADH1A | OPRM1 4381/4885TSHR 2444/4885THRB 2198/4885 |
| US-20090203817-A1 | STABILIZED SPANDEX COMPOSITIONS | SMCHD1, SMC1A, SI | OPRM1 3881/4885TSHR 4633/4885THRB 4809/4885 |
| US-20100324314-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | ADH1C, ADH5, ADH1A | OPRM1 4280/4885TSHR 2452/4885THRB 2104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.